Celia Hagan, Vice President


Celia Hagan, MPH joined the firm in 2018. Her primary focus is on the National Independent Laboratory Association, global health, infectious diseases and regulatory affairs. Her expertise brings together science and policy to help shape national health outcomes. Celia excels at translating complex scientific concepts and developing strategic plans to meet client needs. She has experience working with several federal agencies including the FDA, CDC, CMS and HRSA. 

Celia previously worked at the Association of Public Health Laboratories where she focused on regulatory and policy issues related to laboratory developed tests, public health emergencies, human subject research protections, device reclassification and laboratory reimbursement. During her tenure at APHL she provided strategic direction and strengthened the Association’s capacity to respond to regulatory issues affecting public health laboratories, including challenges surrounding emergency use authorization in public health emergencies. She also advocated on Capitol Hill for a strong public health laboratory network. Prior to APHL, Celia worked in the laboratory at the Fred Hutchinson Cancer Research Center and at a clinical hematology laboratory in Seattle, WA. Celia holds a BA in Biochemistry, Biophysics and Molecular Biology from Whitman College and an MPH from the Johns Hopkins School of Public Health.

Celia Hagan can be reached at chagan@dc-crd.com